National Pharmaceutical Pricing Authority

STUDY OF CC, PC, PL NORMS IN RESPECT OF DRUG FORMULATIONS : QUESTIONNAIRE INDEX

Sl. No.	Proforma No.	Details
--	--	Guidelines
--	--	General Information
1	A	Installed / Achievable Capacity and Actual Production
2	B	Production and Process Loss Dosage form wise
3	C	Cost Centre wise Capacity and Production
4	C1	Assessment of Installed Capacity of Production Cost Centres
5	C2	Assessment of Installed Capacity of Packing Cost Centres
6	D	Break-up of Profit & Loss Account Unit-Wise
7	E	Reconciliation Statement
8	E1	Allocation of Depreciation to Formulation Activity
9	F	Re-allocation of Direct & Common Expenditure for Formulation Division – Unit-wise
10	F1	Electricity Load of Various Departments
11	G	Allocation of Expenses relating to own Formulation Activity – Unit-wise
12	H	Absorption of Conversion Cost and Packing Cost to various Products
13	I	Production Data
14	J	Details of Process Loss and Packing Material Loss
15	K	Conversion Cost, Process Loss & Packing Charges in respect of Formulations
16	L	Processing Charges as per DPCO and Actually paid in respect of Loan Licence from Others
17	M	Processing Charges as per DPCO and Actually Received in respect of Loan Licence for Others
18	N	Basis for indexing listed variable elements for indexing with a view to allow escalation in conversion cost and packing charges. Basis of developing index for adjusting process loss.

Last Page Updated: 30-10-2018

Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)

STUDY OF CC PC PL NORMS IN RESPECT OF DRUG FORMULATIONS :...